Provided by Tiger Fintech (Singapore) Pte. Ltd.

MEI Pharma

2.23
-0.0600-2.62%
Post-market: 2.230.00000.00%16:42 EDT
Volume:2.12K
Turnover:4.78K
Market Cap:14.86M
PE:-0.47
High:2.31
Open:2.31
Low:2.21
Close:2.29
Loading ...
Feb 27, 2024

Correspondence

Form CORRESP - Correspondence
Feb 21, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 27, 2023

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report
Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Oct 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 13, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 13, 2023

Correspondence

Form CORRESP - Correspondence
Oct 03, 2023

Major Issues Report

Form 8-K - Current report